Jain-Ghai Shailly, Joffe Ari R, Bond Gwen Y, Siriwardena Komudi, Chan Alicia, Yap Jason Y K, Hajihosseini Morteza, Dinu Irina A, Acton Bryan V, Robertson Charlene M T
Department of Medical Genetics University of Alberta Edmonton Alberta Canada.
Department of Pediatrics University of Alberta Edmonton Alberta Canada.
JIMD Rep. 2020 Jan 27;52(1):43-54. doi: 10.1002/jmd2.12095. eCollection 2020 Mar.
Urea cycle disorders (UCD) and organic acid disorders classically present in the neonatal period. In those who survive, developmental delay is common with continued risk of regression. Liver transplantation improves the biochemical abnormality and patient survival is good. We report the neurocognitive and functional outcomes post-transplant for nine UCD, three maple syrup urine disease, and one propionic acidemia patient.
Thirteen inborn errors of metabolism (IEM) patients were individually one-to-two matched to 26 non-IEM patients. All patients received liver transplant. Wilcoxon rank sum test was used to compare full-scale intelligence-quotient (FSIQ) and Adaptive Behavior Assessment System-II General Adaptive Composite (GAC) at age 4.5 years. Dichotomous outcomes were reported as percentages.
FSIQ and GAC median [IQR] was 75 [54, 82.5] and 62.0 [47.5, 83] in IEM compared with 94.5 [79.8, 103.5] and 88.0 [74.3, 97.5] in matched patients (-value <.001), respectively. Of IEM patients, 6 (46%) had intellectual disability (FSIQ and GAC <70), 5 (39%) had autism spectrum disorder, and 1/13 (8%) had cerebral palsy, compared to 1/26 (4%), 0, 0, and 0% of matched patients, respectively. In the subgroup of nine with UCDs, FSIQ (64[54, 79]), and GAC (56[45, 75]) were lower than matched patients (100.5 [98.5, 101] and 95 [86.5, 99.5]), = .005 and .003, respectively.
This study evaluated FSIQ and GAC at age 4.5 years through a case-comparison between IEM and matched non-IEM patients post-liver transplantation. The neurocognitive and functional outcomes remained poor in IEM patients, particularly in UCD. This information should be included when counselling parents regarding post-transplant outcome.
尿素循环障碍(UCD)和有机酸血症通常在新生儿期发病。存活下来的患儿常伴有发育迟缓,且有病情倒退的持续风险。肝移植可改善生化异常情况,患者生存率良好。我们报告了9例尿素循环障碍、3例枫糖尿症和1例丙酸血症患者肝移植后的神经认知和功能转归情况。
13例先天性代谢缺陷(IEM)患者与26例非IEM患者进行个体一对一或二对一匹配。所有患者均接受了肝移植。采用Wilcoxon秩和检验比较4.5岁时的全量表智商(FSIQ)和适应性行为评估系统-II综合适应能力(GAC)。二分结局以百分比形式报告。
IEM患者的FSIQ和GAC中位数[四分位数间距]分别为75[54, 82.5]和62.0[47.5, 83],而匹配患者的分别为94.5[79.8, 103.5]和88.0[74.3, 97.5](P值<.001)。IEM患者中,6例(46%)有智力残疾(FSIQ和GAC<70),5例(39%)有自闭症谱系障碍,1/13例(8%)有脑性瘫痪,而匹配患者中分别为1/26例(约4%)、0例、0例和0%。在9例尿素循环障碍亚组中,FSIQ(64[54, 79])和GAC(56[45, 75])低于匹配患者(100.5[98.5, 101]和95[86.5, 99.5]),P值分别为.005和.003。
本研究通过肝移植后IEM患者与匹配的非IEM患者的病例对照,评估了4.5岁时的FSIQ和GAC。IEM患者,尤其是尿素循环障碍患者的神经认知和功能转归仍然较差。在向家长咨询移植后结局时应包含此信息。